The Innovation Crisis: Why True Skincare Breakthroughs Matter More Than Ever
While the beauty industry debates ingredient stagnation, Goodier is committed to defining and delivering genuine innovation for our clients.
Recent Mintel research reveals that only 35% of global CPG launches in early 2024 were truly new products—the lowest proportion since tracking began in 1996. The remaining 65% were merely "renovations" (line extensions, reformulations, new packaging, or relaunches).
This raises questions about how many of these "new" products deliver real innovation, which is defined as new benefits, superior consumer experiences, or enhanced efficacy.
At Goodier, we define innovation clearly: the ability to create, develop, deliver, and scale new products, services, processes, and business models for customers. "New" is the operative word.
To reverse the downward innovation trend, Goodier challenges both ourselves and the industry to elevate standards by ensuring:
New ingredients and combinations must deliver novel benefits or superior efficacy compared to existing solutions
Example: Exosomes represent interesting technology, but do they outperform peptides or work better in combination with them?
Products must offer genuinely new benefits or enhanced performance
Example: Delivering meaningful sleep benefits that enhance skin repair over time
Example: Surpassing industry leaders (like CE Ferulic) in antioxidant capacity and brightening efficacy
New launches must address technical or consumer challenges
Example: Stabilizing formulas with Ascorbic Acid while improving delivery depth
Example: Reducing irritation while enhancing the delivery of Retinols and Vitamin C
Products must demonstrate superior regimens with supporting data
Device + topical combinations for synergistic results
Films + topical applications for enhanced effectiveness
Masks + topical products for improved outcomes
Goodier is prepared to invest in helping our clients drive true innovation to stimulate new growth in the skincare market.